Over half of all patients who receive chemotherapy for the treatment of cancer develop cognitive problems. According to a recent study, this cognitive dysfunction is linked to a perturbation of three types of glial cells present in the white matter of the brain, suggesting that medications which target these cells could diminish the undesirable effects of chemotherapy on cognition. Download the column